Pharma Investments, Ventures & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Adverse Drug Reactions
DrugLogic(R) Announces Qscan(R)-Clinical - a Drug Safety System for Clinical Development
March 9th, 2008
DrugLogic(R), Inc. an established provider of post-market drug safety analytic and data solutions, announced Qscan(R)-Clinical, a workflow database and analytical system that supports all phases of clinical development. Analogous to the well-known role of the FDA AERS database in Qscan(R)-ERM, Qscan-Clinical will include a database of marketed drug label data to assist in comparator study design and data analysis. Clients already using Qscan-ERM with their proprietary post-market safety data will be able to extend their licenses to include the new features and databases. Qscan-Clinical joins the expanding family of Qscan solutions and will be offered in three modes: (a)...
Source: Pharma Investments, Ventures & Law Weekly (2008-03-09)
|
